Zilong (Allen) Wang (HEL Trading (Beijing) Co., Ltd.)

Wang, Zilong (Allen) (HEL Group 202302– promoted to General Manager of H.E.L. China before Malvern Pananalytical)

	Organisation	HEL Trading (Beijing) Co., Ltd.
	Group	HEL (H.E.L.) (Group)
	Former/major organisation	Malvern Panalytical Ltd.
	Group	Spectris (Group)
	Product	laboratory equipment and instruments

H.E.L. Group. (2/8/23). "Press Release: H.E.L Group appoints Allen Wang as General Manager of H.E.L China". London.

> Appointment follows successful expansion of operations in China and transition to direct sales model

> Supports next phase in H.E.L’s development as China becomes significant contributor to commercial growth

H.E.L Group (H.E.L), a global developer and manufacturer of innovative laboratory tools for process optimization, safety, and scale-up, today announced the appointment Wang Zilong (Allen Wang) as General Manager (GM) of H.E.L China. Allen takes over as GM from Qing (Steven) Chen, who led the transition to a wholly foreign-owned entity (WFOE) in the country and drove recent growth in H.E.L China’s core markets of battery testing and process safety. As Steven starts his retirement, Allen will drive the next stage of regional development including expansion into new application areas and the ongoing commercial effectiveness of the business.

Allen has been promoted into the role of GM from his position as Sales Manager and Applications Specialist at H.E.L China. He brings to the role extensive sales and business development experience within H.E.L’s installed base and wider industry and academic contacts in China. Prior to joining H.E.L, Allen worked at a variety of international analytical and imaging instrument companies including Malvern Pananalytical, Bruker Optics, Nanophoton and Techcom where he built technical, sales and service skills in the research and development of batteries and energy, catalysts, materials sciences, and pharmaceuticals. During his 15 years’ experience in the scientific instrument sector, he has led product marketing and business development initiatives across China, with a focus on driving new business, territory development and customer relationships within academia and battery, fine chemicals and pharmaceutical markets.

Louise Madden, CEO of H.E.L Group, commented: "We're delighted to welcome Allen into his new role as GM as we take our business in China to its next stage and expand beyond our core application markets. China is now one of our largest commercial regions, and I would like to take this opportunity to thank Steven, our retiring GM, for his experience and leadership in creating such a solid foundation and delivering substantial growth. With Allen now on board, we look forward to building on this for further expansion of the business and continued success."

Allen Wang, General Manager, H.E.L China added: "Going to a direct sales model in China has been a great success and I have enjoyed working alongside Steven and the team during the transition. I now look forward to leading the next stage of growth for H.E.L China, knowing that I can still call on Steven’s wealth of experience as he remains involved in our business."

For more information please see www.helgroup.com or www.helgroup.cn

ENDS

Notes to Editors

For further information, please contact:

Zyme Communications
Sarah Jeffery
Tel: +44 (0)7771 730919
E-mail: sarah.jeffery@zymecommunications.com

About H.E.L Group www.helgroup.com

H.E.L Group's mission is to work together with chemistry, safety, and biotechnology experts to engineer and unleash the full potential of the scientific community. To this end, H.E.L develops and manufactures innovative scientific instruments and software designed to optimize the efficiency, safety, and productivity of key processes in chemistry and biology applications.

The H.E.L team of over 80 includes highly skilled process and software engineers, based at their extensive research and manufacturing facilities in the UK, as well as sales and support offices around the world.

H.E.L has a long history of solving complex challenges for customers. For more than 30 years, the Company has worked with businesses and laboratories globally, providing proprietary automated solutions for the pharma, biotechnology, chemical, battery, and petrochemical sectors.

Following significant growth, and with annual revenues exceeding £10 million, the Company is extending the reach of its products to support and enable R&D and process optimization further across the US, China, Asia-Pacific, and India.

Follow H.E.L Group on Twitter @hel_group and LinkedIn @H.E.L Group